Risk factors for a severe form of COVID-19 after allogeneic haematopoietic stem cell transplantation: a Société Francophone de Greffe de Moelle et de Thérapie cellulaire (SFGM-TC) multicentre cohort study
ContributorsXhaard, Alienor; Xhaard, Constance; D'Aveni, Maud; Salvator, Helene; Chabi, Marie-Laure; Berceanu, Ana; Coman, Tereza; Beguin, Yves; Chalandon, Yves; Poiré, Xavier ; Loschi, Michaël; Paillard, Catherine; Bruno, Benedicte; Ceballos, Patrice; Dalle, Jean-Hugues; Bilger, Karin; Bay, Jacques-Olivier; Robin, Marie; N'Guyen-Quoc, Stephanie; Rubio, Marie-Therese
Published inBritish journal of haematology, vol. 192, no. 5, p. e121-e124
Publication date2021-03
First online date2021-02-01
Keywords
- Adolescent
- Adult
- Aged
- Allografts
- COVID-19 / complications
- COVID-19 / diagnostic imaging
- COVID-19 / mortality
- Child
- Child, Preschool
- Cohort Studies
- France / epidemiology
- Hematopoietic Stem Cell Transplantation / adverse effects
- Humans
- Immunosuppressive Agents / adverse effects
- Kaplan-Meier Estimate
- Middle Aged
- Retrospective Studies
- Risk Factors
- SARS-CoV-2
- Thrombocytopenia / etiology
- Transplantation Conditioning / adverse effects
- Young Adult
Affiliation entities
Citation (ISO format)
XHAARD, Alienor et al. Risk factors for a severe form of COVID-19 after allogeneic haematopoietic stem cell transplantation: a Société Francophone de Greffe de Moelle et de Thérapie cellulaire (SFGM-TC) multicentre cohort study. In: British journal of haematology, 2021, vol. 192, n° 5, p. e121–e124. doi: 10.1111/bjh.17260
Main files (1)
Article (Published version)
Secondary files (1)
Identifiers
- PID : unige:158639
- DOI : 10.1111/bjh.17260
- PMID : 33522598
- PMCID : PMC8013848
Commercial URLhttps://onlinelibrary.wiley.com/doi/10.1111/bjh.17260
Journal ISSN0007-1048